PACS vs LFST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PACS

38.0
AI Score
VS
PACS Wins

LFST

37.1
AI Score

Investment Advisor Scores

PACS

38score
Recommendation
AVOID NEW MONEY

LFST

37score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric PACS LFST Winner
Forward P/E 18.7617 59.8802 PACS
PEG Ratio 1.2502 0 Tie
Revenue Growth 11.5% 25.3% LFST
Earnings Growth 15.6% 2020.6% LFST
Tradestie Score 38.0/100 37.1/100 PACS
Profit Margin 4.9% 4.3% PACS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED LFST

Relative Price Performance (Last 90 Days)

PACS 1M: +10.8% · 3M: +8.0% LFST 1M: +16.7% · 3M: +19.1%

Current Technical Phase

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 58

RSI (14): 57.6 · Price: $49.10

LFST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.8% over 20 days), RSI 68

RSI (14): 68.0 · Price: $14.56

Fundamentals Snapshot

Metric PACS LFST
Market Cap — —
Forward P/E 17.5 33.8
Trailing P/E 28.2 81.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.1%
EPS 1.73 0.18
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.